Stocktwits on MSN
SLS stock pops after-hours as loss shrinks, cash swells — all eyes on high stakes AML trial in 'pivotal' 2026
Net loss in FY25 narrowed to $26.9 million from $30.9 million a year ago, with R&D costs falling to $16 million. ・Phase 3 Regal AML trial nears final analysis, with 72 of 80 required survival events ...
24/7 Wall St. on MSN
SELLAS stock up 346% in a year as cancer vaccine trial nears its final 8 deaths
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in ...
NASA is heading back to the moon, and it's planning to use the long-delayed Space Launch System (SLS) to get there. The agency is working to assemble the first SLS rocket, which will be the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results